Fundraising Fox
/Companies
Sign in

Samphire Neuroscience

Founded 2021 · 12 employees on LinkedIn · 11 known investors

Find your way into Samphire Neuroscience

Sign up to see every warm intro you have to Samphire Neuroscience

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Samphire Neuroscience team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Samphire Neuro develops brain-based neurotechnology medical devices to treat chronic pain and mood conditions in women, targeting PMDD, dysmenorrhea, perimenopause, chronic migraines, and endometriosis. Its flagship non-invasive neurostimulation headband has clearance in the UK and EU and is expanding into the United States.

Digital HealthFemTechMedical Devices

Founders & leadership

Samphire Neuroscience was founded in 2021 by Emilė Radytė and Alex Cook.

EREmilė Radytė
Emilė RadytėCEO (Founder)Emilė Radytė is a neuroscientist and co-founder and CEO of Samphire Neuroscience, which develops neurotechnology medical devices to treat conditions including PMDD, dysmenorrhea, perimenopause, chronic migraines, and endometriosis.
ACAlex Cook
Alex CookCOO (Founder)
EBErvinas Bern
Ervinas BernCTOErvinas Bern is CTO of Samphire Neuroscience, which develops neurostimulation medical devices for chronic pain and mood conditions. He has worked in non-invasive brain stimulation and laser science.
KC
Kendell CannonChief Medical Officer

Investors · 11

Alberts Impact Ventureslisted by Alberts Impact VenturesSydney

How we know: Alberts Impact Ventures's portfolio page · Not right? Tell us

Angel Academelisted by Angel AcademeLondon · $11K – $385K

How we know: Angel Academe's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

CVX Ventureslisted by CVX VenturesCopenhagen · $15K – $250.6K

How we know: CVX Ventures's portfolio page · tech.eu · Not right? Tell us

Firstpicklisted by FirstpickVilnius · $110K – $550K

How we know: tech.eu · open dataset · 5k.vc investor directory · Not right? Tell us

Fortify Ventureslisted by Fortify VenturesWashington · $100K – $2M

How we know: a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us

Inventurelisted by InventureHelsinki

How we know: Inventure's portfolio page · Not right? Tell us

Seaside Ventureslisted by Seaside VenturesBoulder · $250K

How we know: Seaside Ventures's portfolio page · a partner's Signal profile · tech.eu · Not right? Tell us

SOSVlisted by SOSVNew York · $30K – $550K

How we know: tech.eu · open dataset · 5k.vc investor directory · sosv.com · Not right? Tell us

Ayuh VenturesreportedSan Francisco

How we know: tech.eu · Not right? Tell us

InventurereportedHelsinki · $330K – $5.5M

How we know: the VCSheet dataset · Not right? Tell us

Funding

SEC filings, press & company announcements

$2.3M disclosed across 1 of 2 rounds · 2024–2025

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 4

Flo HealthFlo is a women's health app offering personalized cycle tracking, fertility guidance, pregnancy support, and health education backed by a medical team. The app serves women and people with periods globally with science-based insights on hormonal health from first period to perimenopause.
ClueClue is a menstrual and reproductive health app that lets people track their periods, cycle, ovulation, fertility, and related symptoms, and contributes anonymized data to scientific research with institutions such as Johns Hopkins and the Gates Foundation. The company offers a paid Clue Plus subscription and serves over 12 million users worldwide.
Natural CyclesNatural Cycles offers an FDA-cleared mobile app that uses a user's body temperature data and an algorithm to predict fertile windows for hormone-free birth control and pregnancy planning. The app supports women's health across life stages from contraception through perimenopause and is certified in over 35 countries.
UbieUbie provides a free AI-powered symptom checker that generates a personalized report on possible causes of a user's symptoms and guidance on when to see a doctor, based on a short questionnaire developed with doctors. The consumer-facing digital health service operates in Japan, the United States, and other countries.

Companies working in the same space as Samphire Neuroscience.

In the news

London-based Samphire Neuroscience raises €2.1 million to launch wearable that targets PMS and menstrual pain | EU-Startupseu-startups.com · Feb 2024

Frequently asked questions

What does Samphire Neuroscience do?
Samphire Neuro develops brain-based neurotechnology medical devices to treat chronic pain and mood conditions in women, targeting PMDD, dysmenorrhea, perimenopause, chronic migraines, and endometriosis. Its flagship non-invasive neurostimulation headband has clearance in the UK and EU and is expanding into the United States.
Who founded Samphire Neuroscience?
Samphire Neuroscience was founded by Emilė Radytė, Alex Cook in 2021.
Who are Samphire Neuroscience's investors?
Samphire Neuroscience's investors include AfterWork Ventures, Alberts Impact Ventures, Angel Academe, CVX Ventures, Firstpick, Fortify Ventures, Inventure, Seaside Ventures and 3 more.
How much funding has Samphire Neuroscience raised?
Samphire Neuroscience has disclosed $2.3M raised across 1 of its 2 known rounds.